New Hampshire Health Report
SEE OTHER BRANDS

Get your fresh news on health and wellness in New Hampshire

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on May 29, 2025

Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology

Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology

Access the video here BOSTON and LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the release of a “Meet the Team” …

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

RA'ANANA, Israel, May 29, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic shift to accelerate the …

Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner

Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner

Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale of its NeuSight PET-CT 64-slice scanner to a prominent …

Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers

Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers

GRAND CAYMAN, Cayman Islands, May 29, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors. "As we continue to …

Penn Highlands State College Partners with SAFE-T System to Provide Support for Victims of Sexual Assault

Penn Highlands State College Partners with SAFE-T System to Provide Support for Victims of Sexual Assault

DuBois, Pennsylvania, May 29, 2025 (GLOBE NEWSWIRE) -- Penn Highlands State College is partnering with Sexual Assault Forensic Examination-Telehealth (SAFE-T) System to enhance sexual assault care in the Centre County region. “We are excited to partner …

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection …

Lantern’s Cancer Program Reaches 1 Million Member Milestone

Lantern’s Cancer Program Reaches 1 Million Member Milestone

DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Lantern, the leading Specialty Care Platform connecting approximately 6 million members with the best surgery, cancer and infusion care, recently announced the expansion of its cancer program to serve 1 million …

Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting

Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting

BETHESDA, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

Organic Living Soil LLC Joins Easy Environmental Solutions as Exclusive Dealer in Louisiana and Mississippi Following Initial Shipment

Organic Living Soil LLC Joins Easy Environmental Solutions as Exclusive Dealer in Louisiana and Mississippi Following Initial Shipment

WELCOME, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), now doing business as Easy Environmental Solutions Inc., is proud to announce that Organic Living Soil, LLC has agreed to be the exclusive dealer/warehouser for …

Drug Device Combination Products Market worth US$379.17 billion by 2030 with 9.3% CAGR | MarketsandMarkets™.

Drug Device Combination Products Market worth US$379.17 billion by 2030 with 9.3% CAGR | MarketsandMarkets™.

Delray Beach, FL, May 29, 2025 (GLOBE NEWSWIRE) -- The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, …

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, …

Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders Cortigent is developing the Orion® Visual Cortical Prosthesis System to provide meaningful …

atai Life Sciences to Participate in Upcoming Investor Conferences

atai Life Sciences to Participate in Upcoming Investor Conferences

NEW YORK and BERLIN, May 29, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences  (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, …

Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Second Oncology Candidate (VTX-0P4) in a Prostate Stem Cell Antigen (PSCA) Related Tumor Study in Combination with a Checkpoint…

Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Second Oncology Candidate (VTX-0P4) in a Prostate Stem Cell Antigen (PSCA) Related Tumor Study in Combination with a Checkpoint…

Study conducted at The Massachusetts General Hospital’s Vaccine and Immunotherapy Center demonstrated highly significant improvements in Overall Survival and other key endpoints VTX-0P4, in combination with a CPI, had a statistically significant …

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 Company Corrects Record on Common Misconceptions Regarding the Reverse Stock Split Proposal SOUTH SAN …

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, …

Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client

Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client

OREM, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in ultra-low temperature freezer technology, today announced the successful completion of a major installation project valued at $550,000. The deployment, which …

KALA BIO to Present at Jefferies Global Healthcare Conference

KALA BIO to Present at Jefferies Global Healthcare Conference

ARLINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today …

Septerna to Present at Jefferies Global Healthcare Conference

Septerna to Present at Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief Executive …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service